ATE409458T1 - Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen - Google Patents

Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen

Info

Publication number
ATE409458T1
ATE409458T1 AT02721011T AT02721011T ATE409458T1 AT E409458 T1 ATE409458 T1 AT E409458T1 AT 02721011 T AT02721011 T AT 02721011T AT 02721011 T AT02721011 T AT 02721011T AT E409458 T1 ATE409458 T1 AT E409458T1
Authority
AT
Austria
Prior art keywords
treatment
prevention
mucous
affections
dosage forms
Prior art date
Application number
AT02721011T
Other languages
English (en)
Inventor
Jeremy Jacob
David Nowotnik
Christiane Baud
Original Assignee
Access Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Access Pharma Inc filed Critical Access Pharma Inc
Application granted granted Critical
Publication of ATE409458T1 publication Critical patent/ATE409458T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02721011T 2001-02-15 2002-02-15 Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen ATE409458T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26904901P 2001-02-15 2001-02-15

Publications (1)

Publication Number Publication Date
ATE409458T1 true ATE409458T1 (de) 2008-10-15

Family

ID=23025584

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02721011T ATE409458T1 (de) 2001-02-15 2002-02-15 Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen

Country Status (11)

Country Link
US (1) US7547433B2 (de)
EP (2) EP1363600B1 (de)
AT (1) ATE409458T1 (de)
CA (1) CA2441352C (de)
CY (1) CY1108678T1 (de)
DE (1) DE60229109D1 (de)
DK (2) DK1997478T3 (de)
ES (2) ES2437846T3 (de)
NZ (1) NZ549469A (de)
PT (2) PT1363600E (de)
WO (1) WO2002064113A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343492B1 (de) * 2000-11-22 2006-02-01 Rxkinetix, Inc. Behandlung von mukositis
GB0126064D0 (en) * 2001-10-30 2001-12-19 Reckitt Benckiser Healthcare Improvements in or relating to organic compositions
US7132111B2 (en) * 2003-01-03 2006-11-07 Epien Medical, Inc. Odorless formulation for treating mucosal discontinuities
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
EP1660101A4 (de) * 2003-08-21 2010-02-24 Access Pharma Inc Flüssige formulierungen zur prävention und behandlung von schleimhauterkrankungen und störungen
DE20318634U1 (de) * 2003-11-13 2004-02-26 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
PT1793799E (pt) 2004-08-02 2010-07-29 Glaxosmithkline Consumer Healt Nova composiã†o para tratamento de xerostomia
BRPI0608154A2 (pt) * 2005-02-16 2016-10-11 Wyeth Corp métodos de tratar ou inibir mucosite, cistite por radiação em um indivíduo, e de tratar pelo menos um sintoma de exposição de um indivíduo a um agente citotóxico ou à radiação, e, composição farmacêutica
PL1890732T3 (pl) 2005-06-17 2018-11-30 Wisconsin Alumni Research Foundation Preparaty zwężające naczynia krwionośne do podawania miejscowego i sposoby ochrony komórek podczas chemioterapii i radioterapii przeciwnowotworowej
AU2016202290B2 (en) * 2005-06-17 2017-10-05 Wisconsin Alumni Research Foundation Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PT1965787E (pt) * 2005-11-30 2013-07-05 Endo Pharmaceuticals Inc Tratamento de xerostomia com um antioxidante que contém enxofre
EP2918276A1 (de) * 2006-05-30 2015-09-16 Orahealth Corporation Cobalaminzusammensetzungen und verfahren zur behandlung oder vorbeugung von mucositis
WO2008137831A1 (en) * 2007-05-07 2008-11-13 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Water-soluble nanoparticles containing water-insoluble compounds
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
US20090131386A1 (en) * 2007-11-13 2009-05-21 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
DK3354276T3 (da) 2007-11-13 2020-03-30 Meritage Pharma Inc Sammensætninger til behandlingen af gastrointestinal inflammation
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US8389021B2 (en) * 2009-02-03 2013-03-05 Microbion Corporation Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
WO2010144044A1 (en) * 2009-06-10 2010-12-16 Exthera Ab Use of a composition for the treatment of mucositis
IT1397132B1 (it) * 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
US20110237563A1 (en) * 2010-03-23 2011-09-29 Dominique Costantini Fast dissolving drug delivery systems
US20120053130A1 (en) * 2010-08-30 2012-03-01 Bristol-Myers Squibb Company Composition for enhancing absorption of a drug and method
JP5996553B2 (ja) * 2010-12-30 2016-09-21 ジブ エム．ディー． ハリシュ， 果実および／または野菜との口腔接触に起因する口腔アレルギー症状の表面適用による予防および／または処置のための調製物
WO2012119261A1 (en) * 2011-03-10 2012-09-13 Biocia Inc. Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
KR20140050608A (ko) * 2011-04-19 2014-04-29 암즈 파머수티컬 엘엘씨 유해 미생물 저해 방법 및 그를 위한 장벽-형성 조성물
US10426761B2 (en) * 2011-04-19 2019-10-01 Arms Pharmaceutical, Llc Method for treatment of disease caused or aggravated by microorganisms or relieving symptoms thereof
ES2375784B1 (es) * 2011-12-22 2013-01-24 Laboratorios Kin S.A. Gel de ácido tranexámico
CA2899492C (en) 2013-02-13 2019-09-17 The Procter & Gamble Company Anise flavored medication
WO2014149617A1 (en) * 2013-03-15 2014-09-25 Cook Medical Technologies Llc Adhesive medical products and methods for treating gastrointestinal lesions
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
US9433644B2 (en) 2013-07-25 2016-09-06 Rutgilli Pharmaceuticals, Llc Formulations and methods for treating oral inflammation, injury, or pain
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
WO2015116860A1 (en) * 2014-01-29 2015-08-06 Vita Ice Therapeutics Llc Edible oil compositions to treat oral complications and methods of using same
WO2015126841A1 (en) 2014-02-18 2015-08-27 Plasmatech Biopharmaceuticals, Inc. Nutritional and therapeutic mucoadhesive formulations
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
JP7020915B2 (ja) * 2014-10-27 2022-02-16 エフビーエム インダストリア ファーマシューティカ エルティディエー． 抗炎症性、増殖性、保護性及び粘膜付着性の、可溶性且つ安定な医薬組成物、粘膜部位の状態を治療するためのその使用及び取得方法、並びに医薬組成物の調製のための基本医薬組成物及びその取得方法
AU2017364103C1 (en) * 2016-11-28 2023-12-21 Kenvue Brands Llc Liquid compositions comprising a mucoadhesive agent
US11413240B2 (en) * 2016-12-29 2022-08-16 Board Of Regents, The University Of Texas System Methylene blue solution for the treatment of oral lesions
FR3063226B1 (fr) * 2017-02-28 2020-05-08 Unither Pharmaceuticals Formulation pharmaceutique pour l'administration par voie bucco-gingivale de paracetamol
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
MX2021001276A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos para tratar heridas.
MX2021001272A (es) 2018-07-31 2021-07-15 Microbion Corp Composiciones de bismuto-tiol y metodos de uso.
WO2020084530A1 (en) 2018-10-24 2020-04-30 Ferring B.V. Mucoadhesive pharmaceutical compositions of corticosteroids
WO2021167845A1 (en) 2020-02-18 2021-08-26 Sunstar Americas, Inc. Oral care composition

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
DE3486448T2 (de) 1983-11-14 1997-10-09 Columbia Lab Inc Bioadhäsive Mittel
US4738842A (en) 1986-01-17 1988-04-19 Riker Laboratories Topical antiinflammatory compositions
US4851393A (en) * 1986-07-28 1989-07-25 Massachusetts Institute Of Technology Method for utilizing an exocellular polysaccharide isolated from zoogloea ramigera
US5081158A (en) 1988-05-02 1992-01-14 Zila Pharmaceuticals, Inc. Compositions and in situ methods for forming films on body tissue
ES2134769T3 (es) 1989-10-31 1999-10-16 Columbia Lab Bermuda Ltd Procedimiento y composicion de humidificacion de tejido.
US6017521A (en) 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
EP0431719B1 (de) 1989-10-31 1994-11-09 Columbia Laboratories, Inc. Mittel zur Feuchthaltung vaginalen Gewebes
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5543150A (en) 1993-09-15 1996-08-06 Columbia Laboratories, Inc. Method of progesterone delivery and affect thereof
US5403578A (en) 1994-02-08 1995-04-04 Gordon; Norman Stable tooth and gum dentifrice with microencapsulation and method for making same
US5458879A (en) 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW438601B (en) 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
WO1996009829A1 (en) 1994-09-27 1996-04-04 Virotex Corporation Improved topical carriers for mucosal applications
US5667492A (en) 1994-10-07 1997-09-16 Columbia Laboratories, Inc. Use and composition of an anti-sexually transmitted diseases formulation
US20030098438A1 (en) * 1998-06-29 2003-05-29 Haslin Leonard Arthur Environmentally friendly compositions having antiicing, deicing or graffiti prevention properties
IT1277663B1 (it) * 1995-09-28 1997-11-11 Crinos Industria Farmaco Sospensioni acquose stabili di mesalazina per uso topico
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
US5889028A (en) 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
GB9610862D0 (en) 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
SE9602644D0 (sv) 1996-07-04 1996-07-04 Astra Ab New use
US5989535A (en) * 1997-08-15 1999-11-23 Soma Technologies Polymeric bioadhesive emulsions and suspensions and methods of treatment
US5900230A (en) 1997-08-18 1999-05-04 Squigle, Inc. Dental products to treat and prevent periodontal disease
US6103266A (en) 1998-04-22 2000-08-15 Tapolsky; Gilles H. Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
US20020009478A1 (en) 1998-08-24 2002-01-24 Douglas Joseph Dobrozsi Oral liquid mucoadhesive compositions
ATE481108T1 (de) * 1999-02-26 2010-10-15 Novartis Vaccines & Diagnostic Verwendung von bioadhaesiven und adjuvantien für die mukosale anwendung von antigenen
US6375963B1 (en) 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
ES2343402T3 (es) 2000-03-14 2010-07-30 Alcon, Inc. Viscoelasticos para uso en cirugia del oido medio.
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
US20020103219A1 (en) 2000-10-05 2002-08-01 Jeremy Jacob Stable viscous liquid formulations of amlexanox for the prevention and treatment of mucosal diseases and disorders
US20030060447A1 (en) * 2002-04-24 2003-03-27 Mutlu Karakelle Non-aspirating transitional viscoelastics for use in surgery
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders

Also Published As

Publication number Publication date
EP1363600B1 (de) 2008-10-01
CA2441352A1 (en) 2002-08-22
EP1997478A3 (de) 2008-12-10
CA2441352C (en) 2010-05-25
PT1363600E (pt) 2008-12-22
US7547433B2 (en) 2009-06-16
DK1363600T3 (da) 2009-01-26
EP1997478A2 (de) 2008-12-03
DK1997478T3 (da) 2013-12-09
ES2314049T3 (es) 2009-03-16
EP1363600A1 (de) 2003-11-26
EP1997478B1 (de) 2013-09-04
US20020168334A1 (en) 2002-11-14
PT1997478E (pt) 2013-12-10
ES2437846T3 (es) 2014-01-14
HK1126134A1 (en) 2009-08-28
CY1108678T1 (el) 2014-04-09
WO2002064113A1 (en) 2002-08-22
NZ549469A (en) 2009-02-28
DE60229109D1 (de) 2008-11-13

Similar Documents

Publication Publication Date Title
ATE409458T1 (de) Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
ATE504579T1 (de) Antivirale mittel
NO20060424L (no) 5-heteroringbaserte P38 kinaseinhibitorer
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
ATE318601T1 (de) Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
DE60325379D1 (de) Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
NO20034612L (no) 3,4-di-substituerte syklobuten-1,2-dioner, farmasoytiske preparater som omfatter forbindelsene, samt anvendelse av forbindelsene for tilvirkning av medikamenter for behandling av kjemokinformidlede sykdommer
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
DE60205455T2 (de) Naphthyridinderivate
DE60141636D1 (de) Phospholipidderivate von valproinsäure und ihre kombinationen
ATE407690T1 (de) Topische pharmazeutische zusammensetzungen enthaltend aktive natürliche bestandteile zur verhütung und behandlung von mucosalen entzündungprozessen
DK1057828T3 (da) Orale trovafloxacin-suspensioner
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
AR036357A1 (es) Composicion de gel endoparasiticida, un metodo para su preparacion y el uso de dicha composición para la manufactura de un medicamento.
BR0206549A (pt) Uso de flumazenil na produção de uma droga para o tratamento de dependência de álcool
SE0001916D0 (sv) Novel formulation
DE602006009556D1 (de) Chinolin-derivate zur behandlung von mglur5-rezeptor-vermittelten erkrankungen
DK0561882T3 (da) Hydroxamsyrederivater, som inhiberer lipoxygenase
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1363600

Country of ref document: EP